The immunodeficiency of chronic lymphocytic leukaemia

British Medical Bulletin

Volumn 87, Issue 1, 2008, Pages 49-62

  Hamblin, A D ^a   Hamblin, T J ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Antiretroviral therapy; Hepatitis co infection; HIV; Opportunistic infections; Prevention

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; ANTHRAX VACCINE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ATOVAQUONE; CASPOFUNGIN; CHLORAMBUCIL; CHOLERA VACCINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DAPSONE; DEXAMETHASONE; DIPHTHERIA VACCINE; FLUDARABINE; GANCICLOVIR; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; INFLUENZA VACCINE; ITRACONAZOLE; MENINGOCOCCUS VACCINE; PENATMIDINE; POSACONAZOLE; PREDNISOLONE; RITUXIMAB; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALGANCICLOVIR; VORICONAZOLE;

ANTIBIOTIC PROPHYLAXIS; CELL CONTACT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CYTOKINE RELEASE; CYTOLOGY; GENETICS; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNITY; IMMUNOGLOBULIN DEFICIENCY; IMMUNOLOGY; KNOWLEDGE; MEDICAL RESEARCH; MEDLINE; MYCOSIS; ONCOLOGY; PNEUMOCYSTIS JIROVECI; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SCIENCE; TUMOR CELL; VACCINATION;

AGAMMAGLOBULINEMIA; ANTI-BACTERIAL AGENTS; CANCER VACCINES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; T-LYMPHOCYTES;

EID: 51749087317     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldn034     Document Type: Review

References (38)

1. Hamblin TJ (1987) Chronic lymphocytic leukaemia. Balliere's Clin Haematol, 1, 449-491.
2. Stevenson FK, Hamblin TJ, Stevenson GT, Tutt AL (1980) Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes. J Exp Med, 152,1484-1496.
3. Boughton BJ, Jackson N, Lim S, Smith N (1995) Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia. Clin Lab Haematol, 17, 75-80.
4. Johnston PB, Kay NE (2004) Pathogenesis of impaired cellular immune function in CLL. In Faguet GB (ed.) Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis and Management. Totowa, NJ: Humana Press, 109-121.
5. Hillmen P, Skotnicki AB, Robak T et al. (2007) Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia. J Clin Oncol, 25, 5616-5623.
6. Lazzarino M, Orlandi E, Baldanti F et al. (1999) The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders. Br J Haematol, 107, 877-882.
7. Hisada M, Biggar RJ, Greene MH, Fraumeni JF Jr, Travis LB (2001) Solid tumors after chronic lymphocytic leukemia. Blood, 98, 1979-1981.
8. Hermouet S, Sutton CA, Rose TM et al. (2003) Qualitative and quantitative analysis of human herpes viruses in chronic and acute B cell lymphocytic leukemia and in multiple myeloma. Leukemia, 17, 185-195.
9. Mackus WJ, Frakking FN, Grummels A et al. (2003) Expansion of CMV-specific CD8 + CD45RA + CD27- T cells in B-cell chronic lymphocytic leukemia. Blood, 102, 1057-1063.
10. Pourgheysari B, Khan N, Best D, Bruton R, Nayak L, Moss PA (2007) The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J Virol, 81, 7759-7765.
11. Mous R, Savage P, Remmerswaal EB, van Lier RA, Eldering E, van Oers MH (2006) Redirection of CMV-specific CTL towards B-CLL via CD20-targeted HLA/CMV complexes. Leukemia, 20, 1096-1102.
12. Hamblin TJ (2006) Autoimmune complications of chronic lymphocytic leukemia. Semin Oncol, 33, 230-239.
13. Tam CS, Seymour JF, Prince HM et al. (2006) Treatment-related myelodysplasia following fludarabine combination chemotherapy. Haematologica, 91, 1546-1550.
14. Wadhwa P, Morrison VA (2006) Infectious complications of chronic lymphocytic leukemia. Semin Oncol, 33, 240-249.
15. Ravandi F, O'Brien S (2006) Immune defects in patients with chronic lymphocytic leukemia. Cancer Immunol Immunother, 55, 197-209.
16. Dasanu CA, Alexandrescu DA (2007) Risk of second nonlymphoid neoplasm in chronic lymphocytic leukemia. MedGenMed, 9, 35-48.
17. Rebmann V, Nückel H, Dührsen U, Grosse-Wilde H (2007) HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications. Semin Cancer Biol, 17, 430-435.
18. Teft WA, Kirchhof MG, Madrenas J (2006) A molecular perspective of CTLA-4 function. Ann Rev Immunol, 24, 65-97.
19. hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood, 106, 2018-2025.
20. Messmer D, Telusma G, Wasil T et al. (2004) Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutations status. Mol Med, 10, 7-12.
21. Sampalo A, Navas G, Medina F, Segundo C, Cámara C, Brieva JA (2000) Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction. Blood, 96, 3168-3174.
22. Deaglio S, Vaisitti T, Aydin S et al. (2007) CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential. Blood, 110, 4012-4021.
23. Patten PEM, Buggins AGS, Richards J et al. (2008) CD38 expression in chronic lymphocytic leukemia is regulated by the tumor environment. Blood, 111, 5173-5181.
24. Messmer BT, Messmer D, Allen SL et al. (2005) In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest,115, 755-764.
25. Gricks CS, Zahrieh D, Zauls AJ et al. (2004) Differential regulation of gene expression following CD40 activation of leukemic compared to healthy B cells. Blood, 104, 4002-4009.
26. Buggins AGS, Patten PEM, Richards J, Thomas NSB, Mufti GJ, Devereux S (2008) Tumor-derived IL-6 may contribute to the immunological defect in CLL. Leukemia, 22, 1084-1087.
27. Boldt DH, Van Hoff DD, Kuhn JG, Hersh M (1984) Effect on human peripheral lymphocytes of the in vivo administration of 9-β-D-arabinofuranosyl- 5′-monophosphate (NSC312887) a new purine antimetabolite. Cancer Res, 44, 4661-4666.
28. Alexandrescu DT, Wiernik PH (2008) Serum immunoglobulins as a marker for immune restoration after treatment with high dose rituximab for chronic lymphocytic leukemia. Med Oncol, E-published ahead of print.
29. Oscier D, Fegan C, Hillmen P et al. (2004) Guidelines on the diagnosis and management of chronic lymphocytic leukemia. Br J Haematol, 125, 294-317.
30. Hamblin TJ (2007) Long-lasting response of therapy-resistant viral warts to treatment with interleukin-2 in a patient with chronic lymphocytic leukemia (CLL) and profound immunodeficiency. Leuk Res, 31, 413-414.
31. Morrison VA (2007) Management of infectious complications in patients with chronic lymphocytic leukemia. Hematol Am Soc Hematol Educ Program, 2007, 332-338.
32. Weeks JC, Tierney MR, Weinstein MC (1991) Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. New Engl J Med; 325, 81-86.
33. Hamblin TJ, Verrier Jones J, Peacock DB (1975) The immune response to φX174 in man IV Primary and secondary antibody production in patients with chronic lymphocytic leukaemia. Clin Exp Immunol, 21, 101-108.
34. Sinisalo M (2008) Responses to vaccine antigens in chronic lymphocytic leukaemia. Academic Dissertation. University of Tampere Medical School, Finland. Available at http://acta.uta.fi/pdf/978-951-44-7271-8.pdf
35. Jutel M, Blaser K, Akdis CA (2006) The role of histamine in regulation of the immune response. Chem Immunol Allergy, 91, 174-187.
36. Jurlander J, deNully Brown P, Skov PS et al. (1995) Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukaemia. Leukemia, 9, 1902-1909.
37. Van der Velden AM, Van Velzen-Blad H, Claessen AM et al. (2007) The effect of ranitidine on antibody responses to polysaccharide vaccines in patients with B-cell chronic lymphocytic leukaemia. Eur J Haematol, 79, 47-52.
38. Sinisalo M, Vilpo J, Itala M, Vakevainen M, Taurio J, Aittoniemi J (2007) Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia. Vaccine, 26, 82-87.